VALIANTLABPharmaceuticals
Valiant Laboratories Ltd — PE Ratio & Valuation Analysis
₹51.62
-5.74%
Current P/E72.54xPrice to earnings
Industry P/E31.77xSector average
4Y Avg P/E474.5x84.7% below avg
⚠️
128.3% Premium to Industry
VALIANTLAB P/E 72.54x vs sector avg 31.77x
📊
Historical PE Ratio
| Year | EPS (₹) | Year-end Price | PE Ratio |
|---|---|---|---|
| 2024 | ₹0.12 | ₹111 | 921x |
| 2023 | ₹6.19 | ₹173 | 28x |
PE = Year-end closing price ÷ Diluted EPS. Source: NSE/BSE filings.
💡
Understanding Valiant Laboratories Ltd Valuation
Valiant Laboratories Ltd (VALIANTLAB) currently trades at 72.54x earnings. The Pharmaceuticals sector average PE is 31.77x. VALIANTLAB commands a premium, reflecting high growth expectations. Historically, VALIANTLAB has traded at an average PE of 474.5x — it is currently below that level. Always evaluate PE alongside earnings growth (PEG ratio), return on equity, debt levels and business quality. A lower PE isn't always better. Educational data only — not investment advice.
ROE
-1.43%
Dividend Yield
0.00%
More on Valiant Laboratories Ltd
Data from NSE/BSE public filings. Educational purposes only. Bull Run is not SEBI-registered. Not investment advice.